The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Structure, enzymatic activities, glycation and therapeutic potential of human serum albumin: A natural cargo
Abstract
Human serum albumin (HSA) is an opulent, non-glycosylated, most versatile carrier protein in plasma possessing multiple functions. HSA has the ability to interact with a variety of ligands, including exogenous pharmacological drugs. HSA has multiple binding sites located in different subdomains and which are responsible for binding of ligands. While antecedent research has discovered various functional and structural properties of HSA, the objective of this review paper is to shed light on some of the important properties of HSA and how binding pattern of different ligands can sustain the development of new drugs. Some significant properties include transportation, ligand-binding, distribution and metabolism of a compound. The HSA molecule can undergo various structural changes modifying its conformation and finally affects the ligand binding properties and redox state. Another important feature is an esterase-like activity possessed by HSA, which is also crucial in converting the prodrugs into active therapeutics. Therefore, HSA is one of the most suitable molecules for future research in drug discovery in pharmaceutical industry because of its numerous features and binding pattern that also governs the metabolism and drug dosage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Atomic structure and chemistry of human serum albumin
He, X. M., & Carter, D. C. (1992) · Nature · doi:10.1038/358209a0 · Cited by 3,824
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
All About Albumin: Biochemistry, Genetics, and Medical Applications
Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,372
Carter, D. C., & Ho, J. X. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60640-3 · Cited by 3,187
Antioxidants in health and disease
Young, I. S., & Woodside, J. V. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.3.176 · Cited by 1,949
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., & Curry, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.075 · Cited by 1,941
Crystal structure of human serum albumin at 2.5 Å resolution
Sugio, S., Kashima, A., Mochizuki, S., Noda, M., & Kobayashi, K. (1999) · Protein Engineering, Design and Selection · doi:10.1093/protein/12.6.439 · Cited by 1,786
The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin
SUDLOW, G., BIRKETT, D. J., & WADE, D. N. (1975) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10691-3 · Cited by 1,725
Microvascular Blood Flow Is Altered in Patients with Sepsis
De Backer, D., Creteur, J., Preiser, J.-C., Dubois, M.-J., & Vincent, J.-L. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200109-016oc · Cited by 1,473
Further Characterization of Specific Drug Binding Sites on Human Serum Albumin
SUDLOW, G., BIRKETT, D. J., & WADE, D. N. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10855-9 · Cited by 1,443
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Curry, S., Mandelkow, H., Brick, P., & Franks, N. (1998) · Nature Structural Biology · doi:10.1038/1869 · Cited by 1,377
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
Stamler, J. S., Jaraki, O., Osborne, J., Simon, D. I., Keaney, J., Vita, J., Singel, D., Valeri, C. R., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7674 · Cited by 1,238
The extraordinary ligand binding properties of human serum albumin
Fasano, M., Curry, S., Terreno, E., Galliano, M., Fanali, G., Narciso, P., Notari, S., & Ascenzi, P. (2005) · IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) · doi:10.1080/15216540500404093 · Cited by 1,086
Albumin: Biochemical properties and therapeutic potential†
Quinlan, G. J., Martin, G. S., & Evans, T. W. (2005) · Hepatology · doi:10.1002/hep.20720 · Cited by 984
The role of albumin in critical illness
Nicholson, J. P., Wolmarans, M. R., & Park, G. R. (2000) · British Journal of Anaesthesia · doi:10.1093/bja/85.4.599 · Cited by 939
Practical Aspects of the Ligand-Binding and Enzymatic Properties of Human Serum Albumin.
Kragh-Hansen, U., Chuang, V. T. G., & Otagiri, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.695 · Cited by 892
Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin
Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., & Curry, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100575200 · Cited by 825
Protein Glycation, Diabetes, and Aging
Ulrich, P. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.1 · Cited by 810
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 705
Three-Dimensional Structure of Human Serum Albumin
Carter, D. C., He, X.-M., Munson, S. H., Twigg, P. D., Gernert, K. M., Broom, M. B., & Miller, T. Y. (1989) · Science · doi:10.1126/science.2727704 · Cited by 602
Reaction of Monosaccharides with Proteins: Possible Evolutionary Significance
Bunn, H. F., & Higgins, P. J. (1981) · Science · doi:10.1126/science.12192669 · Cited by 598
Human serum albumin, systemic inflammation, and cirrhosis
Arroyo, V., García-Martinez, R., & Salvatella, X. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.012 · Cited by 560
Binding of the General Anesthetics Propofol and Halothane to Human Serum Albumin
Bhattacharya, A. A., Curry, S., & Franks, N. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005460200 · Cited by 529
Production of Correctly Processed Human Serum Albumin in Transgenic Plants
Sijmons, P. C., Dekker, B. M. M., Schrammeijer, B., Verwoerd, T. C., van den Elzen, P. J. M., & Hoekema, A. (1990) · Nature Biotechnology · doi:10.1038/nbt0390-217 · Cited by 492
Albumin as Fatty Acid Transporter
van der Vusse, G. J. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.300 · Cited by 479
Specific antioxidant properties of human serum albumin
Taverna, M., Marie, A.-L., Mira, J.-P., & Guidet, B. (2013) · Annals of Intensive Care · doi:10.1186/2110-5820-3-4 · Cited by 473
The glycation of albumin: Structural and functional impacts
Rondeau, P., & Bourdon, E. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.003 · Cited by 433
Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I., Bucala, R., & Adamis, A. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1277 · Cited by 423
Biomacromolecules as carriers in drug delivery and tissue engineering
Zhang, Y., Sun, T., & Jiang, C. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.005 · Cited by 416
Nonenzymatic glycosylation of human serum albumin alters its conformation and function.
Shaklai, N., Garlick, R. L., & Bunn, H. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43168-1 · Cited by 415
Complete amino acid sequence of human serum albumin
Meloun, B., Morávek, L., & Kostka, V. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)80242-0 · Cited by 413
Desai, N., Trieu, V., Damascelli, B., & Soon-Shiong, P. (2009) · Translational Oncology · doi:10.1593/tlo.09109 · Cited by 396
Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites.
Iberg, N., & Flückiger, R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67052-8 · Cited by 379
Cisplatin Binding Sites on Human Albumin
Ivanov, A. I., Christodoulou, J., Parkinson, J. A., Barnham, K. J., Tucker, A., Woodrow, J., & Sadler, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.14721 · Cited by 362
Oettl, K., & Stauber, R. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707251 · Cited by 357
The Atomic Structure of Human Methemalbumin at 1.9 Å
Wardell, M., Wang, Z., Ho, J. X., Robert, J., Ruker, F., Ruble, J., & Carter, D. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6540 · Cited by 334
Structure of Human Serum Albumin
Carter, D. C., & He, X.-M. (1990) · Science · doi:10.1126/science.2374930 · Cited by 317
The principal site of nonenzymatic glycosylation of human serum albumin in vivo.
Garlick, R. L., & Mazer, J. S. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32384-6 · Cited by 316
Glucose and free radicals impair the antioxidant properties of serum albumin
BOURDON, E., LOREAU, N., & BLACHE, D. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.233 · Cited by 307
Advanced Glycation End-Products (AGEs) and Heart Failure: Pathophysiology and Clinical Implications
Hartog, J. W. L., Voors, A. A., Bakker, S. J. L., Smit, A. J., & van Veldhuisen, D. J. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.09.009 · Cited by 299
Lessons from the Crystallographic Analysis of Small Molecule Binding to Human Serum Albumin
Curry, S. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.342 · Cited by 298
NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.
Keaney, J. F., Simon, D. I., Stamler, J. S., Jaraki, O., Scharfstein, J., Vita, J. A., & Loscalzo, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116364 · Cited by 298
Rabbani, G., Baig, M. H., Lee, E. J., Cho, W.-K., Ma, J. Y., & Choi, I. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01124 · Cited by 287
Self-citationReviews: Role of Albumin in Human Physiology and Pathophysiology
Doweiko, J. P., & Nompleggi, D. J. (1991) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607191015002207 · Cited by 278
Rabbani, G., Lee, E. J., Ahmad, K., Baig, M. H., & Choi, I. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00976 · Cited by 271
Self-citationCrystallographic Analysis of Human Serum Albumin Complexed with 4Z,15E-Bilirubin-IXα
Zunszain, P. A., Ghuman, J., McDonagh, A. F., & Curry, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.016 · Cited by 267
Structural basis of albumin–thyroxine interactions and familial dysalbuminemic hyperthyroxinemia
Petitpas, I., Petersen, C. E., Ha, C.-E., Bhattacharya, A. A., Zunszain, P. A., Ghuman, J., Bhagavan, N. V., & Curry, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1137188100 · Cited by 259
Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity
WATANABE, H., TANASE, S., NAKAJOU, K., MARUYAMA, T., KRAGH-HANSEN, U., & OTAGIRI, M. (2000) · Biochemical Journal · doi:10.1042/bj3490813 · Cited by 237
Yang, F., Bian, C., Zhu, L., Zhao, G., Huang, Z., & Huang, M. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.08.015 · Cited by 228
Müller, D., Karle, A., Meißburger, B., Höfig, I., Stork, R., & Kontermann, R. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700820200 · Cited by 222
Fernández‐San Millán, A., Mingo‐Castel, A., Miller, M., & Daniell, H. (2003) · Plant Biotechnology Journal · doi:10.1046/j.1467-7652.2003.00008.x · Cited by 202
Kobayashi, K., Kuwae, S., Ohya, T., Ohda, T., Ohyama, M., Ohi, H., Tomomitsu, K., & Ohmura, T. (2000) · Journal of Bioscience and Bioengineering · doi:10.1016/s1389-1723(00)88050-0 · Cited by 198
Allostery in a monomeric protein: The case of human serum albumin
Ascenzi, P., & Fasano, M. (2010) · Biophysical Chemistry · doi:10.1016/j.bpc.2010.03.001 · Cited by 192
Interdomain zinc site on human albumin
Stewart, A. J., Blindauer, C. A., Berezenko, S., Sleep, D., & Sadler, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436576100 · Cited by 190
Analysis and prediction of mammalian protein glycation
Johansen, M. B., Kiemer, L., & Brunak, S. (2006) · Glycobiology · doi:10.1093/glycob/cwl009 · Cited by 189
Surapaneni, M. S., Das, S. K., & Das, N. G. (2012) · ISRN Pharmacology · doi:10.5402/2012/623139 · Cited by 179
Description of a short-term Taxol®-induced nociceptive neuropathy in rats
Authier, N., Gillet, J.-P., Fialip, J., Eschalier, A., & Coudore, F. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02910-3 · Cited by 171
The Amadori product on protein: structure and reactions.
Baynes, J., Watkins, N. G., Fisher, C. I., Hull, C. J., Patrick, J. S., Ahmed, M. U., Dunn, J. A., & Thorpe, S. R. (1989) · PubMed · Cited by 170
Kawakami, A., Kubota, K., Yamada, N., Tagami, U., Takehana, K., Sonaka, I., Suzuki, E., & Hirayama, K. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05341.x · Cited by 170
Acetylation of human serum albumin by p-nitrophenyl acetate
Means, G. E., & Bender, M. L. (1975) · Biochemistry · doi:10.1021/bi00693a031 · Cited by 168
Kratz, F., Müller-Driver, R., Hofmann, I., Drevs, J., & Unger, C. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9905864 · Cited by 166
Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides
Lapolla, A., Fedele, D., Reitano, R., Aricò, N. C., Seraglia, R., Traldi, P., Marotta, E., & Tonani, R. (2004) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2003.11.014 · Cited by 164
Rafikova, O., Rafikov, R., & Nudler, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092048999 · Cited by 158
Ryan, A. J., Ghuman, J., Zunszain, P. A., Chung, C., & Curry, S. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.10.004 · Cited by 156
Fleer, R., Yeh, P., Amellal, N., Maury, I., Fournier, A., Bacchetta, F., Baduel, P., Jung, G., L'Hôte, H., Becquart, J., et al. (1991) · Nature Biotechnology · doi:10.1038/nbt1091-968 · Cited by 155
Bourdon, E., Loreau, N., Lagrost, L., & Blache, D. (2005) · Free Radical Research · doi:10.1080/10715760400024935 · Cited by 154
Sakurai, Y., Ma, S.-F., Watanabe, H., Yamaotsu, N., Hirono, S., Kurono, Y., Kragh‐Hansen, U., & Otagiri, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016241.84630.06 · Cited by 145
Mera, K., Anraku, M., Kitamura, K., Nakajou, K., Maruyama, T., & Otagiri, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.035 · Cited by 145
Structural modifications of human albumin in diabetes
Guérin-Dubourg, A., Catan, A., Bourdon, E., & Rondeau, P. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.11.002 · Cited by 141
Zhu, L., Yang, F., Chen, L., Meehan, E. J., & Huang, M. (2008) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.12.004 · Cited by 137
Virus contaminations of cell cultures – A biotechnological view
Merten, O.-W. (2002) · Cytotechnology · doi:10.1023/a:1022969101804 · Cited by 133
A rapid, simple measurement of human albumin in whole blood using a fluorescence immunoassay (I)
Choi, S., Choi, E. Y., Kim, D. J., Kim, J. H., Kim, T. S., & Oh, S. W. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.10.002 · Cited by 133
Structural Mechanism of Ring-opening Reaction of Glucose by Human Serum Albumin
Wang, Y., Yu, H., Shi, X., Luo, Z., Lin, D., & Huang, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.467027 · Cited by 128
Pseudo-esterase Activity of Human Albumin
Lockridge, O., Xue, W., Gaydess, A., Grigoryan, H., Ding, S., Schopfer, L. M., Hinrichs, S. H., & Masson, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802555200 · Cited by 127
Varshney, A., Rehan, M., Subbarao, N., Rabbani, G., & Khan, R. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017230 · Cited by 125
Self-citationSleep, D., Belfield, G., & GOODEY, A. R. (1990) · Nature Biotechnology · doi:10.1038/nbt0190-42 · Cited by 123
Redox State of Human Serum Albumin in Terms of Cysteine-34 in Health and Disease
Oettl, K., & Marsche, G. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)74011-8 · Cited by 121
Wa, C., Cerny, R. L., Clarke, W. A., & Hage, D. S. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.06.011 · Cited by 121
Lysine residue 199 of human serum albumin is modified by acetylsalicylic acid
Walker, J. E. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80496-6 · Cited by 118
Role of Tyr84 in controlling the reactivity of Cys34 of human albumin
Stewart, A. J., Blindauer, C. A., Berezenko, S., Sleep, D., Tooth, D., & Sadler, P. J. (2004) · FEBS Journal · doi:10.1111/j.1742-4658.2004.04474.x · Cited by 115
Aldini, G., Gamberoni, L., Orioli, M., Beretta, G., Regazzoni, L., Facino, R. M., & Carini, M. (2006) · Journal of Mass Spectrometry · doi:10.1002/jms.1067 · Cited by 115
Yamagishi, S., Takeuchi, M., Inagaki, Y., Nakamura, K., & Imaizumi, T. (2003) · PubMed · Cited by 114
Binding and Hydrolysis of Soman by Human Serum Albumin
Li, B., Nachon, F., Froment, M.-T., Verdier, L., Debouzy, J. C., Brasme, B., Gillon, É., Schopfer, L. M., Lockridge, O., & Masson, P. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700339m · Cited by 114
Melder, R. J., Osborn, B. L., Riccobene, T. A., Kanakaraj, P., Wei, P., Chen, G., Stolow, D. T., Halpern, W., Migone, T., Wang, Q., et al. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0624-7 · Cited by 113
Sokołowska, M., Wszelaka‐Rylik, M., Poznański, J. T., & Bal, W. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.04.011 · Cited by 109
Targeted Expression of Human Serum Albumin to Potato Tubers
Farrán, I., Sánchez‐Serrano, J. J., Medina, J. F., Prìeto, J., & Mingo‐Castel, A. M. (2002) · Transgenic Research · doi:10.1023/a:1016356510770 · Cited by 102
Structural and functional insights into S-thiolation of human serum albumins
Nakashima, F., Shibata, T., Kamiya, K., Yoshitake, J., Kikuchi, R., Matsushita, T., Ishii, I., Giménez‐Bastida, J. A., Schneider, C. G., & Uchida, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-19610-9 · Cited by 102
Effects of Fatty Acids on Two Specific Drug Binding Sites on Human Serum Albumin
Birkett, D., Myers, S., & Sudlow, G. (1977) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12512-1 · Cited by 98
Serum Albumin Binding and Esterase Activity: Mechanistic Interactions with Organophosphates
Goncharov, N. V., Belinskaia, D. A., Shmurak, V. I., Terpilowski, M. A., Jenkins, R. O., & Avdonin, P. V. (2017) · Molecules · doi:10.3390/molecules22071201 · Cited by 95
Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils
Tessari, P. (2003) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200301000-00012 · Cited by 93
Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin
Kisugi, R., Kouzuma, T., Yamamoto, T., Akizuki, S., Miyamoto, H., 染谷, 泰., Yokoyama, J., Abe, I., Hirai, N., & Ohnishi, A. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.001 · Cited by 93
Anaphylactic shock caused by formaldehyde in a patient undergoing long-term hemodialysis
Maurice, F., Rivory, J. P., Larsson, P. H., Johansson, S. G. O., & Bousquet, J. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90351-9 · Cited by 86
Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid.
Salvi, A., Carrupt, P., Mayer, J. M., & Testa, B. (1997) · PubMed · Cited by 78
Ascenzi, P., Colasanti, M., Persichini, T., Muolo, M., Polticelli, F., Venturini, G., Bordo, D., & Bolognesi, M. (2000) · Biological Chemistry · doi:10.1515/bc.2000.081 · Cited by 73
Transition States for Glucopyranose Interconversion
Lewis, B. E., Choytun, N., Schramm, V. L., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0573054 · Cited by 72
Barnaby, O. S., Cerny, R. L., Clarke, W., & Hage, D. S. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.05.012 · Cited by 72
130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain
Wiedenmann, N. E., Valdecanas, D. R., Hunter, N. R., Hyde, S. J., Buchholz, T. A., Milas, L., & Mason, K. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2534 · Cited by 71
Ring, J., Stephan, W., & BRENDEL, W. (1979) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1979.tb01527.x · Cited by 70
Torres, M. J., Turell, L., Botti, H., Antmann, L., Carballal, S., Ferrer‐Sueta, G., Radí, R., & Álvarez, B. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.03.011 · Cited by 69
The role of recombinant proteins in the development of serum-free media
Keenan, J., Pearson, D., & CLYNES, M. M. (2006) · Cytotechnology · doi:10.1007/s10616-006-9002-y · Cited by 68
Blache, D., Bourdon, E., Salloignon, P., Lucchi, G., Ducoroy, P., Petit, J., Vergès, B. L., & Lagrost, L. (2014) · Diabetes · doi:10.2337/db14-0879 · Cited by 59
Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
Presle, N., Lapicque, F., Maurice, M. H., Fournel‐Gigleux, S., Magdalou, J., Abiteboul, M., Siest, G., & Netter, P. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08584-0 · Cited by 49
Lluch, A. M., Álvarez, I., Muñoz-Mateu, M., Seguí, M. Á., Tusquets, I., & García‐Estévez, L. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.08.001 · Cited by 48
Serum albumins and detoxication of anti-cholinesterase agents
Sogorb, M. A., & Vilanova, E. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.03.001 · Cited by 47
Recent Topics in Chemical and Clinical Research on Glycated Albumin
Ueda, Y., & Matsumoto, H. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814567225 · Cited by 46
Schalkwijk, C., Chaturvedi, N., Twaafhoven, H., van Hinsbergh, V. W. M., Stehouwer, C. D. A., & the EUCLID Study Group (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01011.x · Cited by 45
Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin.
Kwon, C., Maddison, K., LoCastro, L., & Borch, R. F. (1987) · PubMed · Cited by 44
Site specificity of glycation of horse liver alcohol dehydrogenase in vitro
Shilton, B. H., Campbell, R. L., & Walton, D. J. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18067.x · Cited by 40
Fabisiak, J. P., Sedlov, A., & Kagan, V. E. (2002) · Antioxidants and Redox Signaling · doi:10.1089/152308602760599016 · Cited by 37
Bai, X., Wang, Z., Huang, C., Wang, Z., & Chi, L. (2012) · Molecules · doi:10.3390/molecules17088782 · Cited by 36
Barash, I., Faerman, A., Baruch, A., Nathan, M., Hurwitz, D. R., & Shani, M. (1993) · Transgenic Research · doi:10.1007/bf01968839 · Cited by 33
Elucidating the Origin of the Esterase Activity of Human Serum Albumin Using QM/MM Calculations
Phuangsawai, O., Hannongbua, S., & Gleeson, M. P. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506629y · Cited by 32
Palumbo, R., Sottotetti, F., & Bernardo, A. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016639873 · Cited by 32
Aryl acylamidase activity of human serum albumin witho-nitrotrifluoroacetanilide as the substrate
Masson, P., Froment, M.-T., Darvesh, S., Schopfer, L. M., & Lockridge, O. (2007) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701383932 · Cited by 29
Role of albumin as a fatty acid carrier for biosynthesis of lens lipids
Sabah, J. R., McConkey, E., Welti, R., et al. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.08.005 · Cited by 26
Zhao, H. L., Xue, C., Wang, Y., Sun, B., Yao, X. Q., & Liu, Z. M. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.01.008 · Cited by 26
Ge, G., Ai, C., Hu, W., Hou, J., Zhu, L., He, G.-Y., Fang, Z., Liang, S., Wang, F., & Yang, L. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.11.011 · Cited by 23
Zhu, R., Xin, X., Dai, H.-Y., Li, Q., Lei, J.-Y., Chen, Y., & Jin, J. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2012.06.009 · Cited by 22
Identification of glycation at the N-terminus of albumin by gas chromatography-mass spectrometry
Robb, D. A., Olufemi, O., Williams, D. A., & Midgley, J. M. (1989) · Biochemical Journal · doi:10.1042/bj2610871 · Cited by 20
Lee, H., & Kim, I.-H. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00483-4 · Cited by 18
An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action
Berger, V., Richter, F., Zettlitz, K. A., Unverdorben, F., Scheurich, P., Herrmann, A., Pfizenmaier, K., & Kontermann, R. E. (2013) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt044 · Cited by 11
Jacobs, V., May, H. T., Bair, T. L., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13327 · Cited by 3
Ascenzi, P., di Masi, A., Leboffe, L., Fanali, G., & Fasano, M. (2016) · RENDICONTI LINCEI · doi:10.1007/s12210-016-0562-2 · Cited by 2
Cited by
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Low serum albumin: A neglected predictor in patients with cardiovascular disease
Manolis, A. A., Manolis, T. A., Melita, H., Mikhailidis, D. P., & Manolis, A. S. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.004 · Cited by 353
Hyaluronic acid and albumin based nanoparticles for drug delivery
Lei, C., Liu, X.-R., Chen, Q.-B., Li, Y., Zhou, J.-L., Zhou, L.-Y., & Zou, T. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.033 · Cited by 266
Metadata
- Authors
- Rabbani, G., & Ahn, S. N.
- Venue
- International Journal of Biological Macromolecules
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 123
- Pages
- 979-990
- ISSN
- 0141-8130 (ISSN-L)
- OpenAlex
- W2901516736
- Cited by
- 505
- References
- 125
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.